A Study of LY3372993 in Participants With Alzheimer's Disease (AD) and Healthy Participants

Clinical trial NCT04451408 · COMPLETED

Trial details

NCT number: NCT04451408
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Alzheimer Disease Healthy

Start date: 2020-07-07
Primary completion: 2024-11-18
Enrollment: 139

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.